These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 4299625)

  • 21. Natural Derived Surfactant Preparation As a Carrier of Polymyxin E for Treatment of Pseudomonas aeruginosa Pneumonia in a Near-Term Rabbit Model.
    Basabe-Burgos O; Zebialowicz J; Stichtenoth G; Curstedt T; Bergman P; Johansson J; Rising A
    J Aerosol Med Pulm Drug Deliv; 2019 Apr; 32(2):110-118. PubMed ID: 30339061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid Polymyxin/Pseudomonas NP test for rapid detection of polymyxin susceptibility/resistance in Pseudomonas aeruginosa.
    Sadek M; Tinguely C; Poirel L; Nordmann P
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1657-1662. PubMed ID: 32318967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhaled colistin in cystic fibrosis].
    Tamm M; Eich C; Frei R; Gilgen S; Breitenbücher A; Mordasini C
    Schweiz Med Wochenschr; 2000 Sep; 130(39):1366-72. PubMed ID: 11059027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Susceptibility of pathogens isolated from clinical specimens to lividomycin].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1972 Dec; 25(6):343-6. PubMed ID: 4353339
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin.
    Schina M; Spyridi E; Daoudakis M; Mertzanos E; Korfias S
    Int J Infect Dis; 2006 Mar; 10(2):178-9. PubMed ID: 16263315
    [No Abstract]   [Full Text] [Related]  

  • 26. [Colistin inhalation helps against Pseudomonas aeruginosa,].
    Reinhardt D
    MMW Fortschr Med; 2014 Nov; 156(20):40. PubMed ID: 25543364
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro activity of polymyxins in combination with β-lactams against clinical strains of Pseudomonas aeruginosa.
    Mitsugui CS; Tognim MC; Cardoso CL; Carrara-Marroni FE; Botelho Garcia L
    Int J Antimicrob Agents; 2011 Nov; 38(5):447-50. PubMed ID: 21872449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colistin: an antimicrobial for the 21st century?
    Stein A; Raoult D
    Clin Infect Dis; 2002 Oct; 35(7):901-2. PubMed ID: 12228836
    [No Abstract]   [Full Text] [Related]  

  • 29. Activity of colistin against Pseudomonas aeruginosa: inhibition by calcium.
    Davis SD; Iannetta A; Wedgwood RJ
    J Infect Dis; 1971 Dec; 124(6):610-2. PubMed ID: 4331350
    [No Abstract]   [Full Text] [Related]  

  • 30. [In vitro sensitivity of Pseudomonas aeruginosa to gentamicin].
    Cocchi P; Panero C
    Minerva Med; 1967 Nov; 58(95 Suppl):4191-3. PubMed ID: 4295503
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
    J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.
    Cheah SE; Wang J; Nguyen VT; Turnidge JD; Li J; Nation RL
    J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial therapy in experimental pseudomonas infection. II.
    McDaniel RC; Southern PM
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):375-84. PubMed ID: 4364246
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of antibiotics on the phagocytosis and killing of Pseudomonas aeruginosa by rabbit polymorphonuclear leukocytes.
    Nishida M; Mine Y; Nonoyama S; Yokota Y
    Chemotherapy; 1976; 22(3-4):203-10. PubMed ID: 178484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Synergistic activity of isepamicin and beta-lactam antibiotics against Pseudomonas aeruginosa in vitro and in vivo].
    Shiritani Y; Yamaji S; Aoki A; Saigusa M; Yokoiyama S; Gato S; Tsuji A
    Jpn J Antibiot; 1988 Nov; 41(11):1591-9. PubMed ID: 3145343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [CLINICAL STUDIES ON PSEUDOMONAS AERUGINOSA INFECTIONS. 2. ON THE SUSCEPTIBILITY OF PSEUDOMONAS AERUGINOSA TO ANTIBIOTICS, WITH SPECIAL REFERENCE TO COLISTIN].
    TAKIGAMI T; TANI S; KITAMOTO O
    Nihon Densenbyo Gakkai Zasshi; 1964 Feb; 37():401-8. PubMed ID: 14126272
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibiotic administration in bacterial keratitis.
    Davis SD; Sarff LD; Hyndiuk RA
    Arch Ophthalmol; 1982 Jun; 100(6):1010-1. PubMed ID: 7092628
    [No Abstract]   [Full Text] [Related]  

  • 38. Post-antibiotic effect of colistin, alone and in combination with amikacin, on Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Bozkurt-Güzel C; Gerçeker AA
    J Antibiot (Tokyo); 2012 Feb; 65(2):83-6. PubMed ID: 22126897
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bisodic alpha-carboxybenzyl-penicillin (carbenicillin): antimicrobial activity on strains of Pseudomonas aeruginosa].
    Notarrigo A; Patti AM
    Ann Ist Super Sanita; 1974; 10(1-2):26-34. PubMed ID: 4377387
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of colistin sulfate ophthalmic solution in therapy of pseudomonas ocular infections.
    Lund MH
    Ann Ophthalmol; 1971 Aug; 3(8):855-8. PubMed ID: 5005928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.